NVO 6-K: Buyback
Filed with the SEC on · accession 0001171843-26-007260
NVO filed a 6-K (foreign company report) with the SEC on Nov 9, 2026. Novo Nordisk provided an update on its ongoing share repurchase programme, disclosing daily B share purchases from November 3-6, 2026.
Summary of the filing
Novo Nordisk provided an update on its ongoing share repurchase programme, disclosing daily B share purchases from November 3-6, 2026. The company has repurchased 42,604,179 B shares for DKK 11.8 billion since February 4, 2026, as part of a broader DKK 15 billion 12-month programme.
Key details
✦ Ask GOAX AI about this filing — what it means for NVO, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for NVO?
Click hereFrequently asked questions
What did NVO file with the SEC on Nov 9, 2026?
NVO filed a 6-K (Buyback). Novo Nordisk provided an update on its ongoing share repurchase programme, disclosing daily B share purchases from November 3-6, 2026. The company has repurchased 42,604,179 B shares for DKK 11.8 billion since February 4, 2026, as part of a broader DKK 15 billion 12-month programme.
What does a buyback mean for NVO stock?
Usually: fewer shares means each remaining share owns more of the company. It matters whether the company actually buys and at what price.
How do I read a 6-K?
How foreign companies listed in the US report news and events — like an 8-K for them. Look at the exhibit names: "results", "resign", "notice" tell you the topic. Many 6-Ks are routine (meeting notices); results and leadership changes matter most.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 6-K (foreign company report): How foreign companies listed in the US report news and events — like an 8-K for them.
Other NVO SEC filings
Get alerts when NVO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days